Tumor, Node, and Metastasis Classification: 8th Edition Changes
The 8th Edition of the Tumor, Node and Metastasis (TNM) classification of lung cancer will help clinicians refine prognosis.
IASLC 2016
International Cooperation Vital for Preventing Lung Cancer
Controlling tobacco use is vital to managing the threat it poses to public health, but doing so requires a multi pronged approach.
Oncoviruses and Epigenetic Factors May Contribute to Risk of Developing Lung Cancer
Although smoking is clearly a major risk factor, pathogenic viruses acquired from consumption of red meat may be a synergistic causative factor.
Cabozantinib Safe and Effective in RET-rearranged Lung Cancer
Cabozantinib demonstrated safety and efficacy for treating patients with RET-rearranged lung cancer in an open-label, phase 2 trial.
Radiotherapy Doses Evaluated in NSCLC
A randomized phase 2 study found that 30 Grays (Gy) in 1 fraction is equivalent to 60 Gy in 3 fractions in terms of toxicity and survival.
Switching From Docetaxel to Paclitaxel and Bevacizumab in NSCLC
Allowing patients with non-squamous non-small cell lung cancer (NSCLC) to cross over demonstrated a progression-free survival (PFS) benefit.
Multiple Genomic Mutations in Nearly 1% of Patients With NSCLC
Double mutations do not significantly decrease overall survival (OS), but do alter progression-free survival (PFS) under first line treatment.
Brigatinib Shows Promise in ALK-positive NSCLC With Brain Metastases
Brigatinib has shown substantial clinical activity among patients with ALK-positive non-small cell lung cancer (NSCLC) who have brain metastases.
Concurrent Chemo-radiotherapy Viable for Elderly Patients With SCLC
A high percentage of patients with limited-stage small cell lung cancer (SCLC) are elderly, but there is a lack of data concerning the efficacy and safety.
NSCLC Survival Associated With Institutional Differences in Quality of Care
Institutional-level differences in the quality of care of patients with NSCLC are associated with differences in stage-stratified and overall survival (OS).
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in IASLC 2016
Loading... 
Loading...